|
1
|
Roodman GD: Advances in bone biology: the
osteoclast. Endocr Rev. 17:308–332. 1996.PubMed/NCBI
|
|
2
|
Nair SP, Meghji S, Wilson M, et al:
Bacterially induced bone destruction: Mechanisms and
misconceptions. Infect Immun. 64:2371–2380. 1996.PubMed/NCBI
|
|
3
|
Orcel P, Feuga M, Bielakoff J and De
Vernejoul MC: Local bone injections of LPS and M-CSF increase bone
resorption by different pathways in vivo in rats. Am J Physiol.
264:E391–E397. 1993.PubMed/NCBI
|
|
4
|
Chiang CY, Kyritsis G, Graves DT and Amar
S: Interleukin-1 and tumor necrosis factor activities partially
account for calvarial bone resorption induced by local injection of
lipopolysaccharide. Infect Immun. 67:4231–4236. 1999.
|
|
5
|
Itoh K, Udagawa N, Kobayashi K, et al:
Lipopolysaccharide promotes the survival of osteoclasts via
Toll-like receptor 4, but cytokine production of osteoclasts in
response to lipopolysaccharide is different from that of
macrophages. J Immunol. 170:3688–3695. 2003. View Article : Google Scholar
|
|
6
|
Islam S, Hassan F, Tumurkhuu G, et al:
Bacterial lipopolysaccharide induces osteoclast formation in RAW
264.7 macrophage cells. Biochem Biophys Res Commun. 360:346–351.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mörmann M, Thederan M, Nackchbandi I, et
al: Lipopolysaccharides (LPS) induce the differentiation of human
monocytes to osteoclasts in a tumour necrosis factor (TNF)
alpha-dependent manner: a link between infection and pathological
bone resorption. Mol Immunol. 45:3330–3337. 2008.PubMed/NCBI
|
|
8
|
Zou W and Bar-Shavit Z: Dual modulation of
osteoclast differentiation by lipopolysaccharide. J Bone Miner Res.
17:1211–1218. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kadono H, Kido J, Kataoka M, et al:
Inhibition of osteoblastic cell differentiation by
lipopolysaccharide extract from Porphyromonas gingivalis. Infect
Immun. 67:2841–2846. 1999.PubMed/NCBI
|
|
10
|
Xing Q, Ye Q, Fan M, et al: Porphyromonas
gingivalis lipopolysaccharide inhibits the osteoblastic
differentiation of preosteoblasts by activating Notch 1 signaling.
J Cell Physiol. 225:106–114. 2010. View Article : Google Scholar
|
|
11
|
Bandow K, Maeda A, Kakimoto K, et al:
Molecular mechanisms of the inhibitory effect of lipopolysaccharide
(LPS) on osteoblast differentiation. Biochem Biophys Res Commun.
402:755–761. 2010. View Article : Google Scholar
|
|
12
|
Ochi H, Hara Y, Tagawa M, et al: The roles
of TNFR1 in lipopolysaccharide-induced bone loss: dual effects of
TNFR1 on bone metabolism via osteoclastogenesis and osteoblast
survival. J Orthop Res. 28:657–663. 2010.PubMed/NCBI
|
|
13
|
Wattel A, Kamel S, Mentaverri R, et al:
Potent inhibitory effect of naturally occurring flavonoids
quercetin and kaempferol on in vitro osteoclastic bone resorption.
Biochem Pharmacol. 65:35–42. 2003. View Article : Google Scholar
|
|
14
|
Woo JT, Nakagawa H, Notoya M, et al:
Quercetin suppresses bone resorption by inhibiting the
differentiation and activation of osteoclasts. Biol Pharm Bull.
27:504–509. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Siddiqui JA, Swarnkar G, Sharan K, et al:
A naturally occurring rare analog of quercetin promotes peak bone
mass achievement and exerts anabolic effect on osteoporotic bone.
Osteoporos Int. 22:3013–3027. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Prouillet C, Mazière JC, Mazière C, et al:
Stimulatory effect of naturally occurring flavonols quercetin and
kaempferol on alkaline phosphatase activity in MG-63 human
osteoblasts through ERK and estrogen receptor pathway. Biochem
Pharmacol. 67:1307–1313. 2004. View Article : Google Scholar
|
|
17
|
Notoya M, Tsukamoto Y, Nishimura H, et al:
Quercetin, a flavonoid, inhibits the proliferation,
differentiation, and mineralization of osteoblasts in vitro. Eur J
Pharmacol. 485:89–96. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Matsuguchi T, Chiba N, Bandow K, et al:
JNK activity is essential for Atf4 expression and late-stage
osteoblast differentiation. J Bone Miner Res. 24:398–410. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gutiérrez-Venegas G, Jiménez-Estrada M and
Maldonado S: The effect of flavonoids on transduction mechanisms in
lipopolysaccharide-treated human gingival fibroblasts. Int
Immunopharmacol. 7:1199–1210. 2007.PubMed/NCBI
|
|
20
|
Guo C, Hou GQ, Li XD, et al: Quercetin
triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts
and inhibits bone resorption in RAW264.7 cells. Cell Physiol
Biochem. 30:123–136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
|
|
22
|
Kim HK, Cho SG, Kim JH, et al: Mevinolin
enhances osteogenic genes (ALP, type I collagen and osteocalcin),
CD44, CD47 and CD51 expression during osteogenic differentiation.
Life Sci. 84:290–295. 2009. View Article : Google Scholar
|
|
23
|
Thunyakitpisal P, Alvarez M, Tokunaga K,
et al: Cloning and functional analysis of a family of nuclear
matrix transcription factors (NP/NMP4) that regulate type I
collagen expression in osteoblasts. J Bone Miner Res. 16:10–23.
2001. View Article : Google Scholar
|
|
24
|
Kern B, Shen J, Starbuck M and Karsenty G:
Cbfa1 contributes to the osteoblast-specific expression of type I
collagen genes. J Biol Chem. 276:7101–7107. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Komori T, Yagi H, Nomura S, et al:
Targeted disruption of Cbfa1 results in a complete lack of bone
formation owing to maturational arrest of osteoblasts. Cell.
89:755–764. 1997. View Article : Google Scholar
|
|
26
|
Nakashima K, Zhou X, Kunkel G, et al: The
novel zinc finger-containing transcription factor osterix is
required for osteoblast differentiation and bone formation. Cell.
108:17–29. 2002. View Article : Google Scholar
|
|
27
|
Fu H, Doll B, McNelis T and Hollinger JO:
Osteoblast differentiation in vitro and in vivo promoted by
Osterix. J Biomed Mater Res A. 83:770–778. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kurata H, Guillot PV, Chan J and Fisk NM:
Osterix induces osteogenic gene expression but not differentiation
in primary human fetal mesenchymal stem cells. Tissue Eng.
13:1513–1523. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pearson G, Robinson F, Beers Gibson T, et
al: Mitogen-activated protein (MAP) kinase pathways: regulation and
physiological functions. Endocr Rev. 22:153–183. 2001.PubMed/NCBI
|
|
30
|
Xia Z, Dickens M, Raingeaud J, et al:
Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.
Science. 270:1326–1331. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fister S, Günthert AR, Aicher B, et al:
GnRH-II antagonists induce apoptosis in human endometrial, ovarian,
and breast cancer cells via activation of stress-induced MAPKs p38
and JNK and proapoptotic protein Bax. Cancer Res. 69:6473–6481.
2009. View Article : Google Scholar
|
|
32
|
Park GB, Kim YS, Lee HK, et al:
Endoplasmic reticulum stress-mediated apoptosis of EBV-transformed
B cells by cross-linking of CD70 is dependent upon generation of
reactive oxygen species and activation of p38 MAPK and JNK pathway.
J Immunol. 185:7274–7284. 2010. View Article : Google Scholar
|
